These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Optimal pharmacologic treatment of the critically ill patient with obstructive airways disease. Siefkin AD Am J Med; 1996 Jan; 100(1A):54S-61S. PubMed ID: 8610719 [TBL] [Abstract][Full Text] [Related]
5. [Asthma and obstructive bronchopneumopathies: the consensus]. Yernault JC Rev Med Brux; 1996 Sep; 17(4):263-5. PubMed ID: 8927858 [TBL] [Abstract][Full Text] [Related]
6. Emerging trends in the therapy of COPD: bronchodilators as mono- and combination therapies. Fitzgerald MF; Fox JC Drug Discov Today; 2007 Jun; 12(11-12):472-8. PubMed ID: 17532532 [TBL] [Abstract][Full Text] [Related]
7. [Long-term treatment strategy in chronic obstructive pulmonary disease: how to change the course of the disease]. Devillier P; Salvator H; Roche N; Grassin-Delyle S; Naline E; Dorocant S; Neveu H Presse Med; 2014 Dec; 43(12 Pt 1):1368-80. PubMed ID: 25455634 [TBL] [Abstract][Full Text] [Related]
9. Bronchodilators: current and future. Cazzola M; Matera MG Clin Chest Med; 2014 Mar; 35(1):191-201. PubMed ID: 24507846 [TBL] [Abstract][Full Text] [Related]
10. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Qaseem A; Wilt TJ; Weinberger SE; Hanania NA; Criner G; van der Molen T; Marciniuk DD; Denberg T; Schünemann H; Wedzicha W; MacDonald R; Shekelle P; ; ; ; Ann Intern Med; 2011 Aug; 155(3):179-91. PubMed ID: 21810710 [TBL] [Abstract][Full Text] [Related]
11. Treatment Options for Stable Chronic Obstructive Pulmonary Disease: Current Recommendations and Unmet Needs. Yawn BP; Kim V Cleve Clin J Med; 2018 Feb; 85(2 Suppl 1):S28-S37. PubMed ID: 29494330 [No Abstract] [Full Text] [Related]
13. Anticholinergic versus beta 2-agonist on gas exchange in COPD: a comparative study in 15 patients. Pillet O; Manier G; Castaing Y Monaldi Arch Chest Dis; 1998 Feb; 53(1):3-8. PubMed ID: 9632900 [TBL] [Abstract][Full Text] [Related]
14. An international perspective on anticholinergic therapy. Chapman KR Am J Med; 1996 Jan; 100(1A):2S-4S. PubMed ID: 8610714 [TBL] [Abstract][Full Text] [Related]
15. A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease. Sovani MP; Whale CI; Tattersfield AE Drug Saf; 2004; 27(10):689-715. PubMed ID: 15350154 [TBL] [Abstract][Full Text] [Related]
16. A new algorithm for the management of COPD. Cooper CB; Barjaktarevic I Lancet Respir Med; 2015 Apr; 3(4):266-8. PubMed ID: 25890644 [No Abstract] [Full Text] [Related]
18. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD. Hanania NA Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761 [TBL] [Abstract][Full Text] [Related]